Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Dairy Sci ; 103(2): 1193-1207, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31759609

ABSTRACT

Infant formulations are constantly evolving as novel protein ingredients are added to make them more closely mimic the protein profile of human milk; however, precise analytical methods for characterizing and quantifying the major milk proteins in such formulations are currently lacking. This article describes an ultra-performance liquid chromatography-high-resolution mass spectrometry method for intact proteins that can efficiently detect, identify, and characterize the major milk proteins and their proteoforms (phosphorylation status, degree of glycation, genetic variants among others) in ingredients and final products, with an emphasis on detecting and quantifying specific genetic variants of ß-casein in infant formulas. Method sensitivity allows detection of ß-casein A1 in A2-based infant formulas with a limit of detection of 2% (grams of ß-casein A1 per 100 g of total ß-casein). Protein glycation affects signal intensity in a linear fashion, which permits proteins to be quantified from their mass spectrometry signals after correction according to their measured glycation index. The method was validated for the quantification of ß-casein in infant formulas. Repeatability ranged from 2 to 3% and intermediate reproducibility from 5 to 9%. Calculated ß-casein amounts ranged between 77 and 110% of the values based on formulations and published protein profiles for milk. Altogether, this method can be used for general fingerprinting as well as specific characterization and quantification of individual major milk proteins in dairy-based ingredients and products.


Subject(s)
Caseins/analysis , Chromatography, High Pressure Liquid , Infant Formula/chemistry , Mass Spectrometry , Peptide Mapping/methods , Animals , Caseins/chemistry , Caseins/genetics , Cattle , Female , Humans , Milk Proteins/analysis , Milk, Human/chemistry , Reproducibility of Results
2.
Article in English | MEDLINE | ID: mdl-19028988

ABSTRACT

In many contexts, self-renewal and differentiation of stem cells are influenced by signals from their environment, constituting a niche. It is postulated that stem cells compete for local growth factors in the niche, thereby maintaining a balance between the numbers of self-renewing and differentiated cells. A critical aspect of the niche model for stem cell regulation is that the availability of self-renewing factors is limited and that stem cells compete for these factors (Fig. 1). Consequently, the range and concentrations of the niche factors are of critical importance. Now that some of the few self-renewing factors have become identified, aspects of the niche models can be tested experimentally. In this chapter, we address mechanisms of signal regulation that take place at the level of signal-producing cells, constituting a niche for stem cells. We emphasize the biochemical properties and posttranslational modifications of the signals, all in the context of Wnt signaling. We propose that these modifications control the range of Wnt signaling and have critical roles in establishing niches for stem cells in various tissues.


Subject(s)
Drosophila/physiology , Stem Cells/cytology , Stem Cells/physiology , Wnt Proteins/physiology , Animals , Cell Differentiation , Cell Proliferation , Drosophila/cytology , Drosophila/genetics , Drosophila Proteins/chemistry , Drosophila Proteins/genetics , Drosophila Proteins/physiology , Embryonic Stem Cells , Humans , Models, Biological , Protein Processing, Post-Translational , Signal Transduction , Wnt Proteins/chemistry , Wnt Proteins/genetics
3.
Gene Ther ; 11(2): 142-51, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14712298

ABSTRACT

Clinical studies with oncolytic adenoviruses have shown that existing viruses are safe but lack efficacy. To selectively increase the toxicity of oncolytic adenoviruses targeting colon tumours, we have inserted the yeast cytosine deaminase gene (yCD) after the fibre gene in the major late transcript. yCD was expressed using either an internal ribosome entry site (IRES) or by alternative splicing of a new exon analogous to the Ad41 long fibre exon. The IRES-CD virus gave higher yCD expression on Western blots. Both approaches result in yCD expression restricted to the period after viral DNA replication. Viral burst size was reduced by less than approximately 10-fold by 5-fluorocytosine (5-FC), showing that expression of yCD as a late gene is compatible with virus replication. Cytopathic effect assays in colon cancer cell lines showed that both yCD viruses have approximately 10-fold increased toxicity in the presence of the prodrug 5-FC, which is converted to 5-fluorouracil (5-FU) by yCD. Toxicity was higher following addition of 5-FC immediately after infection. The largest gain in toxicity was seen in HT29 colon cancer cells, which are the least permissive colon cancer cells for the parental virus, indicating that the new 5-FC/yCD viruses may have broader applications for colon cancer therapy than their predecessors.


Subject(s)
Colonic Neoplasms/therapy , Flucytosine/therapeutic use , Genetic Therapy/methods , Prodrugs/therapeutic use , Proto-Oncogene Proteins/metabolism , Zebrafish Proteins , Adenoviridae/genetics , Cell Line, Tumor , Colonic Neoplasms/metabolism , Cytosine Deaminase/genetics , Gene Expression , Genetic Engineering , Genetic Vectors/administration & dosage , HT29 Cells , Humans , Transcription, Genetic , Virus Replication , Wnt Proteins
4.
Gene Ther ; 9(4): 270-81, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11896466

ABSTRACT

Mutation of the adenomatous polyposis coli and beta-catenin genes in colon cancer leads to constitutive activation of transcription from promoters containing binding sites for Tcf/LEF transcription factors. We have constructed adenoviruses with Tcf binding sites in the early promoters, in order to target viral replication to colon tumours. Tcf regulation of the E1A promoter confers a 100-fold selectivity for cells with activated wnt signalling in viral burst and cytopathic effect assays. p300 is a coactivator for beta-catenin, and E1A inhibits Tcf-dependent transcription through sequestration of p300, but mutation of the p300 binding site in E1A leads to a 10-fold reduction in cytopathic effect of all of the Tcf-regulated viruses. When Tcf sites are inserted in the E1A, E1B, E2 and E4 promoters the viruses show up to 100 000-fold selectivity for cells with activated wnt signalling.


Subject(s)
Adenoviridae/genetics , Colonic Neoplasms/genetics , Promoter Regions, Genetic/genetics , Signal Transduction/genetics , Trans-Activators , Transcription Factors/genetics , Adenomatous Polyposis Coli/genetics , Adenoviridae/physiology , Adenovirus E1A Proteins/genetics , Cytoskeletal Proteins/genetics , Gene Targeting/methods , Humans , Tumor Cells, Cultured , Virus Replication , beta Catenin
SELECTION OF CITATIONS
SEARCH DETAIL
...